Endogenous Peptide Substances Market

Industry Size, Emerging Trends, Regions, Growth Insights, Opportunities, and Forecast By 2033

Endogenous Peptide Substances Market by Type (Neuropeptides, Hormones, Cytokines, Peptide Hormones, and Bioactive Peptides), by Application (Research, Medicine, Others), and by Region (North America, South America, Europe, Asia Pacific, and Middle East & Africa) – Global Share and Forecast to 2033

Region: Global | Format: Word, PPT, Excel | Report Status: Published

According to the Market Statsville Group (MSG), the Global Endogenous Peptide Substances Market size is expected to grow at a CAGR of 7.2% from 2023 to 2033.

Endogenous peptide substances are naturally occurring short chains of amino acids produced within the body, synthesized by cells and tissues, and help to regulate numerous biological functions. Endogenous peptides are found throughout the human body, including the brain, gastrointestinal tract, and immune system, and their functions are cell signaling, hormone regulation, neurotransmission, and neuromodulation. Endogenous peptides have application in the immune system, act as cytokines to coordinate immune responses, or as antimicrobial peptides to defend against infections.

The demand for endogenous peptide substances in the market is being driven by the increasing awareness of endogenous peptide function in physiological processes. Researchers and healthcare professionals are focused on exploring the use of endogenous peptides in the development of novel treatments for a wide range of medical conditions, such as neurological disorders, metabolic diseases, and immune-related disorders. Thus, the aforementioned factors accelerated the demand for endogenous peptide substances as both diagnostic tools and therapeutic agents. The growing aging population and prevalence of age-related diseases and conditions accelerated the endogenous peptides market growth. Additionally, the demand for more personalized and precision medicine approaches has led to increased investment in therapies that can target specific molecular pathways, boosting the demand for endogenous peptide substance market over the forecast period. The advancements in peptide synthesis and manufacturing technologies to produce endogenous peptides at a larger scale have led to a positive outlook for market demand.

Endogenous Peptide Substances Market Segmental Analysis, 2023-2033

Based on type, the market is divided into neuropeptide, hormones, cytokines, peptide hormones, and bioactive peptides. The neuropeptide is expected to dominate the market in 2023. The growing researchers exploration in treating neurological disorders like Alzheimer's and Parkinson's disease, mental health conditions, and chronic pain management is driving demand for neuropeptides segment growth in the market. According to the Alzheimer's Association, currently, there are over 6 million individuals in the United States living with Alzheimer's disease. The Alzheimer's Association report stated that by the year 2050, this figure is expected to increase significantly to almost 13 million. Similarly, as per the Parkinson's Foundation, at present, there are nearly one million individuals in the United States diagnosed with Parkinson's disease (PD). It is anticipated that by the year 2030, this number will increase to approximately 1.2 million. Parkinson's stands as the second most prevalent neurodegenerative disorder in the U.S., following Alzheimer's disease. Thus, the surging prevalence of Alzheimer's and Parkinson's disease, and other mental health conditions across the globe has significantly fostered the market’s growth over the forecast period. The growing aging population that simultaneously accelerates age-related neurological conditions is another factor contributing to the market’s growth.

Based on the regions, the global endogenous peptide substances market has been segmented across North America, Europe, Asia-Pacific, South America, and the Middle East & Africa. North America accounted for the largest market share of around 40% in 2023. The increasing prevalence of chronic diseases, such as obesity, diabetes, and cardiovascular disorders, has upsurged the demand for innovative therapeutic approaches, resulting in driving the market’s growth. The growing aging population in North America and growing age-related conditions like neurodegenerative diseases, fostering the market demand. North America has a wide and robust research and development infrastructure, that is highly focused on advancing and developing new therapies, thus augmenting the demand for endogenous peptides substance market in the region.

However, Asia-Pacific is expected to project the highest CAGR in the global market over the forecast period. This is due to the increasing prevalence of lifestyle-related diseases, such as diabetes, obesity, and cardiovascular conditions, due to changing dietary habits and urbanization. The increasing aging population in countries like Japan and China results in increasing incidence of age-related diseases, such as neurodegenerative disorders such as Alzheimer's and Parkinson's, which significantly increase the demand for endogenous peptide substances market. Further, governments in countries like Singapore, South Korea, and India are actively promoting research and development initiatives in the life sciences, creating a lucrative growth demand for the market.

Endogenous Peptide Substances Market Key Players, 2023

The Major key players in the global endogenous peptide substances market are:

Recent Developments

  • In April 2023, Assertio Holdings, Inc. acquired Spectrum and its commercial capabilities and ROLVEDON, a novel long-acting G-CSF product. The acquisition will expand its diverse therapeutic categories, and ability to continue growth in the growing endogenous peptide substances market.
  • In December 2020, Endo International plc acquired BioSpecifics Technologies Corp. The acquisition enhanced Endo International’s product offerings and expanded its geographical reach catering to various customers.

Report Scope of the Global Endogenous Peptide Substances Market

This market research study categorizes the endogenous peptide substances market-based on type and application at the global, regional, and country levels.

By Type Outlook (Sales, USD Million, 2019-2033)

  • Neuropeptides
  • Hormones
  • Cytokines
  • Peptide Hormones
  • Bioactive Peptides

By Application Outlook (Sales, USD Million, 2019-2033)

  • Research
  • Medicine
  • Others

By Region Outlook (Sales, USD Million, 2019-2033)

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • Italy
    • France
    • UK
    • Spain
    • Poland
    • Russia
    • The Netherlands
    • Norway
    • Czech Republic
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Indonesia
    • Malaysia
    • Thailand
    • Singapore
    • Australia & New Zealand
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Northern Africa
    • Rest of MEA
       

Frequently Asked Questions

  • Key Issues Addressed
  • What is the market size and growth rate for different segmentations at a global, regional, & country level?
  • What is the customer buying behavior, key takeaways, and Porter's 5 forces of the market?
  • What are the key opportunities and trends for manufacturers involved in the supply chain?
  • What are the fundamental dynamics (drivers, restraints, opportunities, and challenges) of the market?
  • What and how regulations, schemes, patents, and policies are impacting the growth of the market?
  • How will existing companies adapt to the new change in technology?
  • The market player positioning, top winning strategies by years, company product developments, and launches will be?
  • How has COVID-19 impacted the demand and sales of in the market? Also, the expected BPS drop or rise count of the market and market predicted recovery period.
  • Who are the leading companies operating in the market? Also, who are the prominent startups that disrupt the market in coming years?
  • PUBLISHED ON: MARCH, 2024
  • BASE YEAR: 2023
  • FORECAST PERIOD: 2024-2033
  • STUDY PERIOD: 2019 - 2033
  • COMPANIES COVERED: 15
  • COUNTRIES COVERED: 24
  • NO OF PAGES: 237

Want to Review Complete Market Research Report

 
save 20%
$2450 $1950
 
save 25%
$4450 $3338
 
save 30%
$5850 $4095
 
save 35%
$8150 $5298

Budget constraints? Get in touch with us for special pricing

Request for Special Pricing

Customize this Report

  • Buy specific region or segment sections of this report
  • Buy specific region/country level reports
  • Request for Pricing Analysis, Market Dynamics, Recommendation & Conclusion
  • Companies Profiles based on Target Requirement
  • Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
  • Why Choose Market Statsville Group?
  • CXO’s Perspective
  • Real-Time Market AttractivenessIndex
  • Investment Pockets
  • Market Player Positioning
  • Competitive Heatmap
  • Parent &Peer Market Analysis
  • Primary Survey Analysis & Transcripts
  • Premium insights from industry experts
  • Robust Research Methodology
  • Market Trends & Opportunities
  • Market Growth Dynamics
  • Value/Supply Chain Analysis
  • Pre-&-Post Covid Market Scenario
  • Latest Technological Developments
  • Comprehensive Reports
  • 3-Rounds Quality Checks with Complete Assurance
  • Unlimited Post-Sales Support
  • Regular Report Updates
Didn't Get What you are looking for. Share your requirements here
Request for Customization

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. I Accept